Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -72.08%. However, over the past six months, we’ve seen a stronger performance of -22.92%. The price of DYN fallen by 35.88% over the last 30 days. And in the last five days, it has surged by 15.04%.
The stock price for Dyne Therapeutics Inc (DYN) currently stands at $11.4. The stock experienced a substantial increase in the last session, hitting $50.0 after starting at $11.43. The stock’s lowest price was $9.0 before closing at $10.47.
In terms of market performance, Dyne Therapeutics Inc had a fairly uneven.
52-week price history of DYN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Dyne Therapeutics Inc’s current trading price is -75.97% away from its 52-week high, while its distance from the 52-week low is 79.25%. The stock’s price range during this period has varied between$6.36 and $47.45. The Dyne Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 8.0 million for the day, a figure considerably higher than their average daily volume of 2.93 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Dyne Therapeutics Inc (DYN) has experienced a quarterly rise of 13.77% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.62B and boasts a workforce of 191 employees.
Dyne Therapeutics Inc: Analysts’ Ratings Unveiled
As of right now, 9 analysts are rating Dyne Therapeutics Inc as a BUY, 6 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.68, with a change in price of +0.91. Similarly, Dyne Therapeutics Inc recorded 2,775,758 in trading volume during the last 100 days, posting a change of +7.66%.
DYN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DYN stands at 0.21. Similarly, the long-term debt-to-equity ratio is also 0.20.
DYN Stock Stochastic Average
Dyne Therapeutics Inc’s raw stochastic average for the past 50 days is presently 65.97%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 86.49%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 89.79% and 89.14%, respectively.
